Naja Emborg Vinding

421 total citations
21 papers, 243 citations indexed

About

Naja Emborg Vinding is a scholar working on Cardiology and Cardiovascular Medicine, Epidemiology and Internal Medicine. According to data from OpenAlex, Naja Emborg Vinding has authored 21 papers receiving a total of 243 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Cardiology and Cardiovascular Medicine, 7 papers in Epidemiology and 4 papers in Internal Medicine. Recurrent topics in Naja Emborg Vinding's work include Atrial Fibrillation Management and Outcomes (11 papers), Cardiac Arrhythmias and Treatments (7 papers) and Acute Ischemic Stroke Management (6 papers). Naja Emborg Vinding is often cited by papers focused on Atrial Fibrillation Management and Outcomes (11 papers), Cardiac Arrhythmias and Treatments (7 papers) and Acute Ischemic Stroke Management (6 papers). Naja Emborg Vinding collaborates with scholars based in Denmark, United States and United Kingdom. Naja Emborg Vinding's co-authors include Emil Loldrup Fosbøl, Lars Køber, Christian Torp‐Pedersen, Jawad H. Butt, Gunnar Gislason, Christina Kruuse, Jonas Bjerring Olesen, Adelina Yafasova, Søren Paaske Johnsen and Lauge Østergaard and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and Neurology.

In The Last Decade

Naja Emborg Vinding

19 papers receiving 240 citations

Peers

Countries citing papers authored by Naja Emborg Vinding

Since Specialization

Citations

This map shows the geographic impact of Naja Emborg Vinding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naja Emborg Vinding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naja Emborg Vinding more than expected).

Fields of papers citing papers by Naja Emborg Vinding

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naja Emborg Vinding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naja Emborg Vinding. The network helps show where Naja Emborg Vinding may publish in the future.

Co-authorship network of co-authors of Naja Emborg Vinding

This figure shows the co-authorship network connecting the top 25 collaborators of Naja Emborg Vinding. A scholar is included among the top collaborators of Naja Emborg Vinding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naja Emborg Vinding. Naja Emborg Vinding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Disparities Among Immigrants and Native Patients in Denmark With New-Onset Heart Failure With Reduced Ejection Fraction 2025 ·JACC Heart Failure ·(unknown), Naja Emborg Vinding, Jawad H. Butt, (unknown), (unknown), Morten Schou, Emil Loldrup Fosbøl, Brian Bridal Løgstrup, (unknown), Pardeep S. Jhund, Lars Køber, Finn Gustafsson, Naveed Sattar, John J.V. McMurray, Søren Lund Kristensen	0
2	Incident Stroke After First-Time TIA According to ABCD ² Score 2024 ·Neurology ·(unknown), (unknown), Naja Emborg Vinding, Jawad H. Butt, (unknown), Søren Paaske Johnsen, Christina Kruuse, Morten Schou, Christian Torp‐Pedersen, Lars Køber, Emil Loldrup Fosbøl	0
3	Prognosis and antithrombotic practice patterns in patients with recurrent and transient atrial fibrillation following acute coronary syndrome: A nationwide study 2024 ·International Journal of Cardiology ·Jeppe Kofoed Petersen, Jawad H. Butt, Adelina Yafasova, Christian Torp‐Pedersen, Rikke Sørensen, Christina Kruuse, Naja Emborg Vinding, Anna Gundlund, Lars Køber, Emil Loldrup Fosbøl, Lauge Østergaard	2
4	Mortality in heart failure with and without autoimmune disease 2023 ·European Journal of Preventive Cardiology ·Guoli Sun, Mikkel Faurschou, Naja Emborg Vinding, Adelina Yafasova, Søren Lund Kristensen, Ole Ahlehoff, Morten Schou, Emil Loldrup Fosbøl, Lars Køber, Jawad H. Butt	1
5	Perioperative Atrial Fibrillation and One-year Clinical Outcomes in Patients Following Major Emergency Abdominal Surgery 2023 ·The American Journal of Cardiology ·(unknown), Emil Loldrup Fosbøl, Jawad H. Butt, Peter Weeke, Søren Lund Kristensen, Jakob Burcharth, Naja Emborg Vinding, Jeppe Kofoed Petersen, Lars Køber, Morten Vester‐Andersen, Anna Gundlund	3
6	Long-Term Incidence of Ischemic Stroke After Transient Ischemic Attack: A Nationwide Study From 2014 to 2020 2023 ·Circulation ·Naja Emborg Vinding, Jawad H. Butt, (unknown), Søren Lund Kristensen, Søren Paaske Johnsen, (unknown), (unknown), Christina Kruuse, Christian Torp‐Pedersen, Lars Køber, Emil Loldrup Fosbøl	7
7	Incidence of thyroid dysfunction following initiation of amiodarone treatment in patients with and without heart failure: a nationwide cohort study 2022 ·EP Europace ·(unknown), Mads Ersbøll, Naja Emborg Vinding, Jawad H. Butt, Rasmus Rørth, Christian Selmer, (unknown), Ulrik M. Mogensen, Peter Weeke, Christian Jøns, Finn Gustafsson, Emil Loldrup Fosbøl, Lars Køber, Søren Lund Kristensen	9
8	Ischemic Stroke Severity and Mortality in Patients With and Without Atrial Fibrillation 2022 ·Journal of the American Heart Association ·Naja Emborg Vinding, Søren Lund Kristensen, Rasmus Rørth, Jawad H. Butt, Lauge Østergaard, Jonas Bjerring Olesen, Christian Torp‐Pedersen, Gunnar Gislason, Lars Køber, Christina Kruuse, Søren Paaske Johnsen, Emil Loldrup Fosbøl	40
9	Use of torsades de pointes risk drugs among patients with out-of-hospital cardiac arrest and likelihood of shockable rhythm and return of spontaneous circulation: A nationwide study 2022 ·Resuscitation ·(unknown), Camilla Jespersen, Søren Lund Kristensen, Emil Loldrup Fosbøl, Naja Emborg Vinding, Freddy Lippert, Kristian Kragholm, Christian Jøns, Steen Møller Hansen, Lars Køber, Peter Karl Jacobsen, Jacob Tfelt‐Hansen, Peter Weeke	2
10	Long-term Risk of Death and Hospitalization in Patients With Heart Failure and Takotsubo Syndrome: Insights From a Nationwide Cohort 2022 ·Journal of Cardiac Failure ·Jawad H. Butt, Lia E. Bang, Rasmus Rørth, Morten Schou, Søren Lund Kristensen, Adelina Yafasova, Eva Havers‐Borgersen, Naja Emborg Vinding, (unknown), Kristian Kragholm, Christian Torp‐Pedersen, Lars Køber, Emil Loldrup Fosbøl	16
11	Time to Thrombolysis and Long-Term Outcomes in Patients With Acute Ischemic Stroke 2021 ·Stroke ·Adelina Yafasova, Emil Loldrup Fosbøl, Søren Paaske Johnsen, Christina Kruuse, Jeppe Kofoed Petersen, (unknown), Naja Emborg Vinding, Christian Torp‐Pedersen, Gunnar Gislason, Lars Køber, Jawad H. Butt	27
12	Workforce Attachment after Ischemic Stroke – The Importance of Time to Thrombolytic Therapy 2021 ·Journal of Stroke and Cerebrovascular Diseases ·Jawad H. Butt, Kristian Kragholm, Christina Kruuse, Hanne Christensen, Helle K. Iversen, Søren Paaske Johnsen, Rasmus Rørth, Naja Emborg Vinding, Adelina Yafasova, Christine Benn Christiansen, Gunnar Gislason, Christian Torp‐Pedersen, Lars Køber, Emil Loldrup Fosbøl	2
13	Incidence of ischaemic stroke and mortality in patients with acute coronary syndrome and first-time detected atrial fibrillation: a nationwide study 2021 ·European Heart Journal ·Jeppe Kofoed Petersen, Jawad H. Butt, Adelina Yafasova, Christian Torp‐Pedersen, Rikke Sørensen, Christina Kruuse, Naja Emborg Vinding, Anna Gundlund, Lars Køber, Emil Loldrup Fosbøl, Lauge Østergaard	27
14	Time trends in incidence, comorbidity, and mortality of ischemic stroke in Denmark (1996–2016) 2020 ·Neurology ·Adelina Yafasova, Emil Loldrup Fosbøl, M. Christiansen, Naja Emborg Vinding, Charlotte Andersson, Christina Kruuse, Søren Paaske Johnsen, Gunnar Gislason, Christian Torp‐Pedersen, Lars Køber, Jawad H. Butt	21
15	C-reactive protein after coronary artery bypass graft surgery and its relationship with postoperative atrial fibrillation 2020 ·EP Europace ·(unknown), Naja Emborg Vinding, Lauge Østergaard, Jawad H. Butt, Gunnar Gislason, Christian Torp‐Pedersen, Lars Køber, Emil Loldrup Fosbøl	16
16	Time in therapeutic range and risk of thromboembolism and bleeding in patients with a mechanical heart valve prosthesis 2019 ·Journal of Thoracic and Cardiovascular Surgery ·Eva Havers‐Borgersen, Jawad H. Butt, Naja Emborg Vinding, Christian Torp‐Pedersen, Gunnar Gislason, Lars Køber, Emil Loldrup Fosbøl	19
17	Outcomes Among Patients With Atrial Fibrillation and Appropriate Anticoagulation Control 2018 ·Journal of the American College of Cardiology ·Anders Nissen Bonde, Laila Stærk, (unknown), Naja Emborg Vinding, Casper N. Bang, Christian Torp‐Pedersen, Gunnar Gislason, Gregory Y.H. Lip, Jonas Bjerring Olesen	17
18	P4512Time in therapeutic range and risk of thromboembolism and bleeding in patients with mechanical heart valve prosthesis 2018 ·European Heart Journal ·Eva Havers‐Borgersen, Jawad H. Butt, Naja Emborg Vinding, Christian Torp‐Pedersen, Gunnar Gislason, (unknown), (unknown)	1
19	The importance of time in therapeutic range in switching from vitamin K antagonist to non-vitamin K antagonist oral anticoagulants in atrial fibrillation 2018 ·EP Europace ·Naja Emborg Vinding, Anders Nissen Bonde, Rasmus Rørth, Morten Lamberts, Jonas Bjerring Olesen, Gunnar Gislason, Christian Torp‐Pedersen, Lars Køber, Emil Loldrup Fosbøl	8
20	Shifting to a non-vitamin K antagonist oral anticoagulation agent from vitamin K antagonist in atrial fibrillation 2017 ·EP Europace ·Emil Loldrup Fosbøl, Naja Emborg Vinding, Morten Lamberts, Laila Stærk, (unknown), Kasper Gadsbøll, Lars Køber, Gunnar Gislason, Jonas Bjerring Olesen	22

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact